Therapeutic Uses and Neuropsychiatric Liabilities for Cannabinoids in the Treatment of Chronic Pain
Daniel Morgan, PhD, Penn State College of Medicine
The Opioid Receptor: Pivotal Element in Two Substance Use Disorders, but Over-Looked by Most Clinicians
Charles O’Brien, MD, PhD, University of Pennsylvania
The Use of an Animal Model to Understand Individual Vulnerability to Opioid Use Disorder and Novel Avenues for Treatment
Sue Grigson, MS, PhD, Penn State College of Medicine
Decoding Circuit Signatures of Addiction Recovery: Opportunities for Precision Medicine and Novel Interventions
Amit Etkin, MD, PhD, Stanford University
Craving and Opioid Use: What We Think We Know and What We Really Don't Know
Eric Strain, MD, John Hopkins University School of Medicine
5 AMA PRA Category 1 Credits™
This event is being hosted in conjunction with The ASAM Fundamentals of Addiction Medicine: A Live Workshop on Thursday, October 4th. Click here for more information
A package deal is available for those who wish to attend both events. Click here for more information
The American Society of Addiction Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Addiction Medicine has been awarded the highest level of Accreditation with Commendation by the Accreditation Council for Continuing Medical Education (ACCME) as a provider of continuing medical education (CME) for physicians. Accreditation in the ACCME System seeks to assure the medical community and the public that ASAM delivers education that is relevant to clinicians’ needs, evidence-based, evaluated for its effectiveness, and independent of commercial influence.